The Global AMR R&D Hub is a partnership of countries and intergovernmental organisations working to address challenges and improve coordination and collaboration in AMR R&D. Suzanne works to shape their approach to incentives. Previously, she was a freelance researcher and analyst contributing ̶ among other things ̶ to the WHO EURO’s work on TB market in low incidence settings, the DRIVE-AB project, the German Government's 2015 GUARD report and the London School of Economics' 2009 landmark study on antimicrobial resistance incentives in support of the EU’s Swedish presidency. Prior to specialising in pharmaceutical innovation and market failures, she began her career working for the pharmaceutical industry before spending some time managing humanitarian response in conflict settings. She holds degrees in pharmacology and health economics.